US2023038917A1PendingUtilityA1

Composition comprising cannabinoids for relief of pain

67
Assignee: TWEED INCPriority: Nov 2, 2018Filed: Oct 4, 2022Published: Feb 9, 2023
Est. expiryNov 2, 2038(~12.3 yrs left)· nominal 20-yr term from priority
Inventors:Mark Andrew HetheringtonChris Schnarr
A61K 36/3482A61K 36/185A61K 31/192A61K 31/658A61K 9/0014A61K 31/165A61K 31/606A61K 9/107A61K 36/61A61K 45/06A61K 31/196A61K 36/28A61K 31/618A61K 31/05
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present technology generally relates to compositions comprising cannabinoids for relieving pain in a subject and to methods of using such compositions for relieving pain in a subject.

Claims

exact text as granted — not AI-modified
1 . A composition for topical application comprising:
 at least one cannabinoid;   at least one anti-inflammatory agent comprising methyl salicylate; and   at least one botanical extract comprising a eucalyptus extract.   
     
     
         2 . The composition of  claim 1 , wherein the at least one botanical extract further comprises an  Arnica  extract. 
     
     
         3 . The composition of  claim 1 , wherein the at least one cannabinoid is present as an isolate, an extract or a distillate. 
     
     
         4 . The composition of  claim 1 , wherein the at least one cannabinoid comprises CBD, THC, CBG, CBN, CBC, THCV, CBGA, CGCA, CBCA, THCA or CBDA. 
     
     
         5 . The composition of  claim 1 , wherein the at least one cannabinoid comprises CBD. 
     
     
         6 . The composition of  claim 1 , further comprising a terpene or terpenoid. 
     
     
         7 . The composition of  claim 6 , wherein the terpene or terpenoid comprises menthol, camphor, or a combination thereof. 
     
     
         8 . The composition of  claim 1 , wherein the at least one cannabinoid is present in an amount ranging from between about 0.5 wt % and about 10 wt % of the total weight of the composition. 
     
     
         9 . The composition of  claim 1 , wherein the at least one cannabinoid is present in an amount ranging from between about 2 wt % and about 8 wt % of the total weight of the composition. 
     
     
         10 . The composition of  claim 1 , wherein the at least one cannabinoid is present in an amount ranging from between about 2 wt % and about 6 wt % of the total weight of the composition. 
     
     
         11 . The composition of  claim 1 , wherein the at least one anti-inflammatory agent is present in an amount ranging from between about 0.5 wt % and about 90 wt % of the total weight of the composition. 
     
     
         12 . The composition of  claim 1 , wherein the at least one anti-inflammatory agent is present in an amount ranging from between about 1 wt % and about 10 wt % of the total weight of the composition. 
     
     
         13 . The composition of  claim 1 , wherein the at least one anti-inflammatory agent is present in an amount ranging from between about 5 wt % and about 10 wt % of the total weight of the composition. 
     
     
         14 . The composition of  claim 1 , wherein the at least one anti-inflammatory agent is present in an amount of about 5 wt %, about 10 wt %, about 15 wt %, about 20 wt % or about 25 wt % of the total weight of the composition. 
     
     
         15 . The composition of  claim 1 , wherein the at least one botanical extract is present in an amount ranging from between about 0.5 wt % and about 90 wt % of the total weight of the composition. 
     
     
         16 . The composition of  claim 1 , wherein the at least one botanical extract is present in an amount ranging from between about 1 wt % and about 25 wt % of the total weight of the composition. 
     
     
         17 . The composition of  claim 1 , wherein the at least one botanical extract is present in an amount ranging from between about 0.5 wt % and about 10 wt % of the total weight of the composition. 
     
     
         18 . A composition for topical application comprising:
 at least one cannabinoid in an amount ranging from between about 0.5 wt % and about 10 wt % of the total weight of the composition;   at least one anti-inflammatory agent comprising methyl salicylate; and   at least one botanical extract comprising a eucalyptus extract and an  Arnica  extract.   
     
     
         19 . The composition of  claim 18 , further comprising a terpene or terpenoid comprises menthol, camphor, or a combination thereof. 
     
     
         20 . A composition for topical application comprising:
 at least one cannabinoid;   at least one anti-inflammatory agent comprising methyl salicylate;   at least one botanical extract in an amount of between about 1 wt % and about 25 wt % of the total weight of the composition, wherein the at least one botanical extract comprising a eucalyptus extract; and   a terpene or terpenoid comprising menthol, camphor, or a combination thereof.

Join the waitlist — get patent alerts

Track US2023038917A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.